What’s New in Vasculitis

September 3, 2025

This activity will inform rheumatologists and allied medical professionals about improvements toward diagnosing GCA, identifying mimics, and managing therapeutic treatments.

Target Audience

This activity is designed for an audience of physicians.

Learning Objectives

  • Discuss vascular imaging in GCA and compare and identify the advantages of CTAs and MRAs, and GCAs.
  • Discuss updates on therapeutics and how they can be applied beyond prednisone.
  • Identify clues relating to medical history in the initial interview.

Commercial Support
There is no commercial support for this activity.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
Course opens: 
09/03/2025
Course expires: 
09/30/2025
Event starts: 
09/03/2025 - 12:00am EDT
Event ends: 
09/03/2025 - 11:59pm EDT
Cost:
$0.00
Rating: 
0
Baltimore, MD
United States

DISCLOSURES

Name

Relationship

Commercial Interest

Rennie Rhee, MD, MSCE (faculty)

N/A

Nothing to disclose

Dorothy Caputo, MA, BSN, RN – President, AKH Inc

N/A

Nothing to disclose

Michele Bielarski, RN (planner/reviewer)

N/A

Nothing to disclose

AKH Inc Staff and Planners

N/A

Nothing to disclose

MSRD Staff and Planners

N/A

Nothing to disclose

All of the relevant financial relationships listed for these individuals have been mitigated.

 

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Maryland Society for the Rheumatic Diseases. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit

Price

Cost:
$0.00
Please login or register to take this course.